Vitamin D is Not a Protective Factor in ALS

Area of Science:

• Neurology
• Endocrinology
• Biochemistry

Background:

• Vitamin D deficiency is linked to worse outcomes in Amyotrophic Lateral Sclerosis (ALS).
• Understanding vitamin D's role in ALS is crucial for evaluating supplementation strategies.

Purpose of the Study:

• To assess vitamin D levels throughout the course of ALS.
• To investigate the relationship between vitamin D levels, clinical factors, and disease progression in ALS patients.

Main Methods:

• Prospective collection of serum vitamin D concentrations in 125 ALS patients.
• Utilized Cox proportional hazard models to analyze survival data.
• Examined associations with clinical parameters like bulbar onset and body mass index (BMI).

Main Results:

• Mean vitamin D levels were below normal and remained stable during the disease.
• Higher vitamin D concentrations were observed in patients with bulbar onset.
• Vitamin D levels were negatively associated with BMI.
• Vitamin D concentrations predicted a worse prognosis when adjusted for ALSFRS-R and BMI.

Conclusions:

• Vitamin D levels in the ALS cohort mirrored previous findings.
• Higher vitamin D levels were unexpectedly associated with poorer ALS prognosis.
• Further research is needed to explore vitamin D manipulation in ALS management.